2017\u5e7410\u67085\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u696d\u754c\u8abf\u67fb\u306b\u3088\u308a\u3001CRO\uff08\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff09\u304c\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u306e\u8fd1\u4ee3\u5316\u3084\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u7387\u5316\u306b\u5411\u3051\u3066\u3001\u696d\u754c\u5168\u4f53\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u660e\u3089\u304b\u306b\u306a\u308a\u307e\u3057\u305f\u3002CRO\u304c\u624b\u4f5c\u696d\u306e\u30d7\u30ed\u30bb\u30b9\u3084\u30ec\u30ac\u30b7\u30fc\u30b7\u30b9\u30c6\u30e0\u304b\u3089\u8131\u5374\u3057\u3001\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u5c02\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u5c0e\u5165\u3092\u9032\u3081\u3066\u3044\u308b\u3053\u3068\u3092³Ô¹Ï±¬ÁÏ 2017 Unified Clinical Operations Survey: CRO Report<\/a><\/strong>\u306f\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4e00\u65b9\u3067\u3001\u8abf\u67fb\u5bfe\u8c61\u3068\u306a\u3063\u305fCRO\u306f\u3044\u305a\u308c\u3082\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316\u3057\u3066\u30b3\u30b9\u30c8\u3092\u524a\u6e1b\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u54c1\u8cea\u3092\u5411\u4e0a\u3055\u305b\u308b\u305f\u3081\u306b\u306f\u3001\u300cCTMS\u3084EDC\u3001eTMF\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u81ea\u793e\u306e\u81e8\u5e8a\u696d\u52d9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u300d\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n \u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u304a\u3088\u3073\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u306e\u8fd1\u4ee3\u5316<\/strong><\/p>\n \u5168\u4f53\u3068\u3057\u3066\u3001CRO\u306f\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u7ba1\u7406\u3059\u308b\u3046\u3048\u3067\u6cbb\u9a13\u4f9d\u983c\u8005\u3088\u308a\u3082\u81e8\u5e8a\u696d\u52d9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u6d3b\u7528\u3057\u3066\u304a\u308a\u30015\u3064\u4ee5\u4e0a\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5229\u7528\u3057\u3066\u3044\u308b\u5272\u5408\u304c\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u306e38%\u3067\u3042\u308b\u306e\u306b\u5bfe\u3057\u3066CRO\u3067\u306f50%\u306b\u9054\u3057\u3066\u3044\u307e\u3059\u3002\u81e8\u5e8a\u696d\u52d9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u4e2d\u3067CRO\u304c\u6700\u3082\u3088\u304f\u5229\u7528\u3057\u3066\u3044\u308b\u306e\u306fEDC\uff0886%\uff09\u3067\u3001eTMF\uff0862%\uff09\u304c\u305d\u306e\u6b21\u306b\u591a\u304f\u5229\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n \u4e00\u65b9\u3067\u3001\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u30b5\u30a4\u30ed\u5316\u306b\u3088\u3063\u3066\u91cd\u5927\u306a\u554f\u984c\u304c\u751f\u3058\u3066\u3044\u307e\u3059\u3002CRO\u306e4\u5206\u306e3\u8fd1\u304f\uff0872%\uff09\u306f\u300c\u81e8\u5e8a\u8a66\u9a13\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u76f4\u9762\u3059\u308b\u6700\u5927\u306e\u8ab2\u984c\u304c\u3001\u8907\u6570\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u7d71\u5408\u3060\u300d\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u4e8b\u5b9f\u3001\u307b\u307c\u3059\u3079\u3066\uff0896%\uff09\u306eCRO\u306f\u300c\u73fe\u5728\u5229\u7528\u3057\u3066\u3044\u308bCTMS\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u8ab2\u984c\u306b\u3088\u308a\u3001\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u6539\u5584\u304c\u5236\u9650\u3055\u308c\u3066\u3044\u308b\u300d\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002\u300cEDC\u3068\u306e\u7d71\u5408\u300d\uff0850%\uff09\u3082\u7279\u306b\u56de\u7b54\u306e\u591a\u304b\u3063\u305f\u8ab2\u984c\u306e\u3072\u3068\u3064\u3067\u3001CRO\u306e3\u5206\u306e2\uff0864%\uff09\u306f\u300ceTMF\u3068\u306e\u7d71\u5408\u300d\u3082\u8ab2\u984c\u3060\u3068\u7b54\u3048\u3066\u3044\u307e\u3059\u3002<\/p>\n \u3053\u3046\u3057\u305f\u8ab2\u984c\u306f\u3042\u308b\u3082\u306e\u306e\u3001CRO\u306f\u6cbb\u9a13\u4f9d\u983c\u8005\u3088\u308a\u901f\u3044\u30da\u30fc\u30b9\u3067\u81e8\u5e8a\u8a66\u9a13\u74b0\u5883\u306e\u8fd1\u4ee3\u5316\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002eTMF\u5c02\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5229\u7528\u3057\u3066\u3044\u308bCRO\u304c42%\u3067\u3042\u308b\u306e\u306b\u5bfe\u3057\u3066\u6cbb\u9a13\u4f9d\u983c\u8005\u306f31%\u3001Study Start-up\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u901f\u3084\u304b\u306b\u5c0e\u5165\u3057\u3066\u3044\u308bCRO\u304c3\u5206\u306e1\uff0832%\uff09\u3067\u3042\u308b\u306e\u306b\u5bfe\u3057\u3066\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u306f9%\u306b\u7559\u307e\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n \u30c7\u30fc\u30bf\u3092\u6d3b\u7528\u3057\u3066\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u5f37\u5316<\/strong><\/p>\n \u30c7\u30fc\u30bf\u3084\u6307\u6a19\u306e\u6d3b\u7528\u306f\u3001\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u6539\u5584\u306e\u6c7a\u3081\u624b\u3067\u3059\u3002\u3053\u306e\u5206\u91ce\u3067\u306fCRO\u304c\u696d\u754c\u3092\u727d\u5f15\u3057\u3066\u304a\u308a\u3001eTMF \u30c7\u30fc\u30bf\u3092\u5e83\u7bc4\u56f2\u306b\u6d3b\u7528\u3057\u3066\u3044\u308bCRO\u304c\u5168\u4f53\u306e3\u5206\u306e1\uff0835%\uff09\u3092\u5360\u3081\u3066\u3044\u308b\u306e\u306b\u5bfe\u3057\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3067\u306f4\u5206\u306e1\uff0827%\uff09\u306b\u7559\u307e\u3063\u3066\u3044\u308b\u3053\u3068\u304c\u4eca\u56de\u306e\u8abf\u67fb\u3067\u660e\u3089\u304b\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u30c7\u30fc\u30bf\u3092\u5e83\u7bc4\u56f2\u306b\u6d3b\u7528\u3057\u3066\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u6539\u5584\u3057\u3066\u3044\u308bCRO\u306f\u300c\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u6307\u6a19\u306e\u53ef\u8996\u6027\u306e\u5411\u4e0a\u300d\uff0859%\uff09\u3084\u300c\u6587\u66f8\u306e\u81ea\u52d5\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u30fb\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u300d\uff0865%\uff09\u306a\u3069\u306e\u512a\u308c\u305f\u30e1\u30ea\u30c3\u30c8\u3092\u5831\u544a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u3057\u304b\u3057\u3001CRO\u306e3\u5206\u306e1\uff0830%\uff09\u306f\u4f9d\u7136\u3068\u3057\u3066\u300c\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3067\u767a\u751f\u3059\u308b\u30c7\u30fc\u30bf\u3092\u30b7\u30b9\u30c6\u30e0\u5916\u3067\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u3057\u3066\u3044\u308b\u300d\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u304a\u305d\u3089\u304f\u3001\u30b5\u30a4\u30ed\u5316\u3057\u305f\u30b7\u30b9\u30c6\u30e0\u304c\u7d71\u5408\u3055\u308c\u3066\u3044\u306a\u3044\u306a\u3069\u306e\u6280\u8853\u7684\u306a\u5236\u7d04\u304c\u8981\u56e0\u3060\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u305d\u306e\u7d50\u679c\u3001\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u306e\u5229\u7528\u72b6\u6cc1\u306b\u95a2\u3059\u308b\u8cea\u554f\u3067\u306f\u3001\u300c\u8907\u6570\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3057\u305f\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u300d\u3092CRO\u304c\u76f4\u9762\u3057\u3066\u3044\u308b\u6700\u5927\u306e\u8ab2\u984c\u306e\u3072\u3068\u3064\u3068\u3057\u3066\u56de\u7b54\u3057\u3066\u304a\u308a\u3001\u305d\u306e\u305f\u3081\u300c\u53ef\u8996\u6027\u5411\u4e0a\u306e\u5fc5\u8981\u6027\u300d\u3092CRO \u306e\u534a\u6570\uff0854%\uff09\u304c\u6319\u3052\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault\u62c5\u5f53\u306e\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Jennifer Goldsmith\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u30b5\u30a4\u30ed\u5316\u306f\u696d\u754c\u306e\u8db3\u304b\u305b\u306b\u306a\u3063\u3066\u304a\u308a\u3001\u3053\u306e\u8ab2\u984c\u306b\u5bfe\u51e6\u3057\u305f\u3044\u3068\u3044\u3046\u30cb\u30fc\u30ba\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002CRO\u306f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u74b0\u5883\u3092\u8fd1\u4ee3\u5316\u3059\u308b\u305f\u3081\u306b\u3055\u307e\u3056\u307e\u306a\u624b\u6bb5\u3092\u8b1b\u3058\u3066\u304a\u308a\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30e2\u30c7\u30eb\u306e\u666e\u53ca\u306b\u5411\u3051\u3066\u3001\u696d\u754c\u306e\u4e2d\u5fc3\u7684\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ 2017 Unified Clinical Operations Survey: CRO Report<\/a><\/strong>\u3067\u306f\u3001\u4e16\u754c\u5404\u56fd\u306750\u4eba\u306eCRO\u304b\u3089\u7d4c\u9a13\u8ac7\u3084\u610f\u898b\u3092\u96c6\u3081\u3001CRO\u304c\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u7d71\u5408\u3092\u3069\u306e\u3088\u3046\u306b\u9032\u3081\u3066\u3044\u308b\u304b\u3092\u8abf\u67fb\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u8abf\u67fb\u3067\u306f\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30e2\u30c7\u30eb\u306e\u4fc3\u9032\u8981\u56e0\u3084\u969c\u58c1\u3001\u30e1\u30ea\u30c3\u30c8\u3092\u7cbe\u67fb\u3057\u3001\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u3084\u81e8\u5e8a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u52b9\u7387\u5316\u3057\u3088\u3046\u3068\u3059\u308b\u52d5\u5411\u3092\u8abf\u67fb\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2017\u5e7410\u67085\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-40735","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40735"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=40735"}],"version-history":[{"count":6,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40735\/revisions"}],"predecessor-version":[{"id":40742,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40735\/revisions\/40742"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=40735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=40735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=40735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067550\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2017. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"